Mary E Yaden

Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, USA.

2 papers in the library · 12 citations · publishing 2024-2026

Papers

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.

Pharmacological research January 1, 2024 David B Yaden, Andrea P Berghella, Peter S Hendricks et al. 12 citations

Classic psychedelic-assisted therapies show initial promise for treating substance use disorders (SUDs) and may become legally available options. This article describes how these therapies could fit within current evidence-based SUD treatments, suggesting broad compatibility with most mainstream clinical approaches.

DOI: 10.1016/j.phrs.2023.106998 Full text Psilocybin Substance use disorder Psychedelic therapy Medication assisted treatment +5

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.

Journal of psychopharmacology (Oxford, England) January 1, 2026 Jack E Henningfield, Frederick S Barrett, Suzette M Evans et al.

Roland R. Griffiths was a highly influential scientist in behavioral and neuropsychopharmacology, known for his rigorous research on abuse liability of substances including alcohol, benzodiazepines, caffeine, tobacco, and psychedelics. This review, authored by his former mentees and collaborators, describes his methodical approach to research, his inclusive and collegial mentoring style, and his role in advancing scientific methods for abuse liability assessment, policy, and regulation. His work culminated in the establishment of the Johns Hopkins Center for Psychedelic and Consciousness Research, reflecting his curiosity-driven, humanity-serving science that continues to inspire innovation.

DOI: 10.1177/02698811251398801 Full text Abuse liability Caffeine Psychedelics Sedatives +1